Skip to main content
Year archive

EyeGene,Inc — 2021 filings

All 81 regulatory filings released by EyeGene,Inc (185490) in 2021, sourced directly from the official regulator.

81 Filings
2021 Period
2021 filings (81)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2021-12-15 Korean
분기보고서 (2021.09)
Interim / Quarterly Report 9M 2021
2021-11-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-11-15 Korean
기타경영사항(특허권취득)(자율공시)(면역반응 조절물질 및 양이온성 리포좀을 포함하는 면역증강용 조성물 및 이의 용도)
Regulatory Filings
2021-10-15 Korean
기타경영사항(특허권취득)(자율공시)(면역반응 조절물질을 포함하는 백신 조성물)
Regulatory Filings
2021-10-15 Korean
신주인수권행사
Share Issue/Capital Change
2021-09-24 Korean
[기재정정]신주인수권행사
Share Issue/Capital Change
2021-09-24 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-09-06 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2021-09-03 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-09-03 Korean
기타경영사항(특허권취득)(자율공시)(면역반응 조절물질 및 양이온성 리포좀을 포함하는 면역증강용 조성물 및 이의 용도)
Regulatory Filings
2021-08-31 Korean
기타경영사항(특허권취득)(자율공시)(면역반응 조절물질을 포함하는 백신 조성물)
Regulatory Filings
2021-08-31 Korean
투자판단관련주요경영사항(mRNA 기반 코로나-19 예방백신 (EG-COVID) 국내 임상 제 1/2a상 시험 계획 (IND) 승인)
Legal Proceedings Report
2021-08-31 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-08-26 Korean
반기보고서 (2021.06)
Interim / Quarterly Report H1 2021
2021-08-17 Korean
[기재정정]사업보고서 (2020.12)
Annual Report FY 2020
2021-08-17 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-08-09 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-07-21 Korean
투자판단관련주요경영사항(당뇨망막증치료제 ‘EG-Mirotin’ 국내 2상 임상시험 완료)
Regulatory Filings
2021-07-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-07-12 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-07-12 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-07-12 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-07-12 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-07-09 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-07-09 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-07-05 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-07-05 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-07-05 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-07-05 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-07-05 Korean
투자판단관련주요경영사항(mRNA 기반 코로나-19 예방백신 (EG-COVID) 국내 임상 제 1/2a상 시험 계획 (IND) 승인 신청)
Regulatory Filings
2021-06-30 Korean
권리락(무상증자)
Share Issue/Capital Change
2021-06-25 Korean
증권발행실적보고서
Share Issue/Capital Change
2021-06-25 Korean
증권발행결과(자율공시)
Share Issue/Capital Change
2021-06-25 Korean
[기재정정]주요사항보고서(유무상증자결정)
Capital/Financing Update
2021-06-22 Korean
유상증자또는주식관련사채등의청약결과(자율공시)
Share Issue/Capital Change
2021-06-18 Korean
유상증자최종발행가액확정
Share Issue/Capital Change
2021-06-15 Korean
[발행조건확정]증권신고서(지분증권)
Capital/Financing Update
2021-06-15 Korean
[기재정정]주요사항보고서(유무상증자결정)
Share Issue/Capital Change
2021-06-15 Korean
[기재정정]투자설명서
Capital/Financing Update
2021-06-15 Korean
투자판단관련주요경영사항(대상포진 예방백신 ‘EG-HZ’ 호주 1상 임상시험 완료)
Legal Proceedings Report
2021-06-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-06-11 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-06-11 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-06-11 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-06-11 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-06-11 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-06-03 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-06-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-06-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-06-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-06-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-06-02 Korean
[기재정정]증권신고서(지분증권) (2021.06)
Capital/Financing Update
2021-05-18 Korean
[기재정정]투자설명서
Investor Presentation
2021-05-18 Korean
투자설명서
Capital/Financing Update
2021-05-17 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-05-17 Korean
분기보고서 (2021.03)
Interim / Quarterly Report Q1 2021
2021-05-17 Korean
유상증자1차발행가액결정
Capital/Financing Update
2021-05-12 Korean
[기재정정]주요사항보고서(유무상증자결정)
Share Issue/Capital Change
2021-05-12 Korean
권리락(유상증자)
Share Issue/Capital Change
2021-05-12 Korean
[발행조건확정]증권신고서(지분증권)
Capital/Financing Update
2021-05-12 Korean
[기재정정]유상증자1차발행가액결정
Share Issue/Capital Change
2021-05-12 Korean
전환청구권행사
Share Issue/Capital Change
2021-05-11 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2021-05-10 Korean
[기재정정]증권신고서(지분증권) (2021.06)
Capital/Financing Update
2021-04-29 Korean
주주명부폐쇄기간또는기준일설정
Share Issue/Capital Change
2021-04-13 Korean
[기재정정]주요사항보고서(유무상증자결정)
Share Issue/Capital Change
2021-04-13 Korean
주요사항보고서(유무상증자결정)
Share Issue/Capital Change
2021-04-12 Korean
주권매매거래정지(무상증자)
Share Issue/Capital Change
2021-04-12 Korean
증권신고서(지분증권)
Capital/Financing Update
2021-04-12 Korean
[기재정정]정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2021-04-07 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update
2021-03-29 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2021-03-25 Korean
감사보고서제출
Audit Report / Information FY 2020
2021-03-17 Korean
[기재정정]감사보고서제출
Audit Report / Information FY 2020
2021-03-17 Korean
사업보고서 (2020.12)
Annual Report FY 2020
2021-03-17 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2021-03-10 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2021-03-03 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2020
2021-02-24 Korean
기타경영사항(특허권취득)(자율공시)(면역반응 조절물질 및 양이온성 리포좀을 포함하는 면역증강용 조성물 및 이의 용도)
Regulatory Filings
2021-02-16 Korean
기타경영사항(자율공시)([국책과제] 백신실용화기술개발사업단, 신변종감염병백신개발플랫폼- 신속 백신 제작 플랫폼 개발 사업 선정)
Regulatory Filings
2021-01-22 Korean